In this study, we established that the Hb/RDW ratio serves as an independent prognostic indicator for AR-DLBCL, significantly enhancing prognostic discrimination when incorporated with the IPI score for risk stratification. The gene discussed is GSTM1; the disease is diffuse large B-cell lymphoma.